• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样变心肌病患者心脏摄取大量 FDG。

Extensive cardiac FDG uptake in a patient with AL amyloidosis.

机构信息

Cardiology Department, Royal Free London NHS Foundation Trust, Pond Street, London, NW3 2QG, UK.

Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.

出版信息

J Nucl Cardiol. 2023 Aug;30(4):1497-1503. doi: 10.1007/s12350-023-03243-1. Epub 2023 Mar 17.

DOI:10.1007/s12350-023-03243-1
PMID:36930456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10022573/
Abstract

Cardiac AL amyloidosis is a medical emergency causing rapid deterioration of cardiac function; however, it remains to be a diagnostic challenge especially when presenting with unusual symptoms and clinical findings. We present case of a 44-year-old patient with typical angina, persistently elevated troponin and normal epicardial coronary arteries. He was initially treated for myocarditis due to chest pain with troponin rise. However, CMR finding of subendocardial enhancement, increased native T1 values as well as extensive diffuse FDG uptake on PET-CT also suggested inflammatory cardiac conditions. Rapid decline in LV function and clinical deterioration led to further investigations including serum free light chains and bone marrow biopsy which confirmed systemic AL amyloidosis. Although the pathophysiology of unusual FDG PET-CT findings remains unknown, marked myocardial FDG uptake might have been caused by various features that were associated with AL amyloidosis including myocardial cell toxicity/inflammation or microvascular dysfunction. Awareness of these features specific to AL amyloidosis among physicians and description of associated cardiac FDG uptake findings has a potential to aid early diagnosis.

摘要

心脏 AL 淀粉样变是一种医学急症,可导致心脏功能迅速恶化;然而,它仍然是一个诊断挑战,特别是当出现不寻常的症状和临床发现时。我们报告了一例 44 岁患者,其表现为典型心绞痛、肌钙蛋白持续升高和正常心外膜冠状动脉。由于胸痛伴肌钙蛋白升高,他最初被诊断为心肌炎。然而,CMR 发现心内膜下增强、原生 T1 值增加以及 PET-CT 上广泛弥漫性 FDG 摄取也提示存在炎症性心脏疾病。左心室功能的迅速下降和临床恶化导致进一步的检查,包括血清游离轻链和骨髓活检,证实了全身性 AL 淀粉样变性。尽管异常 FDG PET-CT 发现的病理生理学仍不清楚,但明显的心肌 FDG 摄取可能是由与 AL 淀粉样变性相关的各种特征引起的,包括心肌细胞毒性/炎症或微血管功能障碍。医生对 AL 淀粉样变性特有的这些特征的认识以及对相关心脏 FDG 摄取发现的描述,有可能有助于早期诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/c590ec65a851/12350_2023_3243_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/40f486b8d6c1/12350_2023_3243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/90a26faee805/12350_2023_3243_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/faef7a0eacab/12350_2023_3243_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/6e605dfe937b/12350_2023_3243_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/911583bac12b/12350_2023_3243_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/c590ec65a851/12350_2023_3243_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/40f486b8d6c1/12350_2023_3243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/90a26faee805/12350_2023_3243_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/faef7a0eacab/12350_2023_3243_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/6e605dfe937b/12350_2023_3243_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/911583bac12b/12350_2023_3243_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355b/10022573/c590ec65a851/12350_2023_3243_Fig6_HTML.jpg

相似文献

1
Extensive cardiac FDG uptake in a patient with AL amyloidosis.淀粉样变心肌病患者心脏摄取大量 FDG。
J Nucl Cardiol. 2023 Aug;30(4):1497-1503. doi: 10.1007/s12350-023-03243-1. Epub 2023 Mar 17.
2
18 F-FDG Uptake in Pancreatic AL Amyloidosis Associated With Multiple Myeloma.18 F-FDG 摄取在多发性骨髓瘤相关的胰腺 AL 淀粉样变性中的作用。
Clin Nucl Med. 2024 Aug 1;49(8):781-783. doi: 10.1097/RLU.0000000000005296. Epub 2024 May 31.
3
[18F]-fluorodeoxyglucose PET-CT in systemic amyloidosis with cardiac involvement.[18F] - 氟脱氧葡萄糖PET-CT在伴有心脏受累的系统性淀粉样变性中的应用
Rev Esp Cardiol (Engl Ed). 2024 Jul;77(7):596. doi: 10.1016/j.rec.2023.12.002. Epub 2024 Jan 5.
4
Myocardial Uptake of 68Ga-Pentixafor in a Patient With Systemic Amyloidosis.一名系统性淀粉样变性患者心肌对68Ga-喷替沙氟的摄取情况
Clin Nucl Med. 2022 Dec 1;47(12):1118-1120. doi: 10.1097/RLU.0000000000004406. Epub 2022 Sep 6.
5
Feasibility of Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Light-Chain Cardiac Amyloidosis.镓标记成纤维细胞激活蛋白抑制剂 PET/CT 在轻链心脏淀粉样变性中的可行性。
JACC Cardiovasc Imaging. 2022 Nov;15(11):1960-1970. doi: 10.1016/j.jcmg.2022.06.004. Epub 2022 Sep 14.
6
18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves.18F-氟苯丙氨酸和 18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在累及周围神经的系统性免疫球蛋白轻链淀粉样变性中的应用。
Clin Nucl Med. 2016 Feb;41(2):e115-7. doi: 10.1097/RLU.0000000000000947.
7
Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.18F-FDG PET(/CT) 在系统性和局限性淀粉样变性患者中的应用。
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1095-101. doi: 10.1007/s00259-013-2375-1. Epub 2013 Mar 9.
8
18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.18F-FDG PET/CT 在轻链淀粉样变性中的应用:病例系列和文献复习。
Amyloid. 2012 Jun;19(2):94-8. doi: 10.3109/13506129.2012.682833. Epub 2012 May 16.
9
Quantitative [F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis.定量[F] florbetapir PET/CT可能识别系统性AL淀粉样变性患者的肺部受累情况。
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1998-2009. doi: 10.1007/s00259-019-04627-7. Epub 2019 Dec 5.
10
18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma.18F-FDG PET/CT 在原发性 AL 肝淀粉样变性伴多发性骨髓瘤中的应用。
Korean J Radiol. 2011 Sep-Oct;12(5):634-7. doi: 10.3348/kjr.2011.12.5.634. Epub 2011 Aug 24.

本文引用的文献

1
Feasibility of Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Light-Chain Cardiac Amyloidosis.镓标记成纤维细胞激活蛋白抑制剂 PET/CT 在轻链心脏淀粉样变性中的可行性。
JACC Cardiovasc Imaging. 2022 Nov;15(11):1960-1970. doi: 10.1016/j.jcmg.2022.06.004. Epub 2022 Sep 14.
2
Myocardial Edema and Prognosis in Amyloidosis.心肌水肿与淀粉样变的预后。
J Am Coll Cardiol. 2018 Jun 26;71(25):2919-2931. doi: 10.1016/j.jacc.2018.03.536.
3
Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.
心脏淀粉样变中的蛋白毒性:淀粉样变轻链影响人心脏细胞内的蛋白质水平。
Sci Rep. 2017 Nov 15;7(1):15661. doi: 10.1038/s41598-017-15424-3.
4
Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.心肌内炎症预示着心脏 AL 淀粉样变性患者的不良预后。
Eur J Heart Fail. 2018 Apr;20(4):751-757. doi: 10.1002/ejhf.1039. Epub 2017 Oct 25.
5
AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.AL(轻链)心脏淀粉样变:诊断与治疗的综述。
J Am Coll Cardiol. 2016 Sep 20;68(12):1323-41. doi: 10.1016/j.jacc.2016.06.053.
6
Systemic amyloidosis.系统性淀粉样变性。
Lancet. 2016 Jun 25;387(10038):2641-2654. doi: 10.1016/S0140-6736(15)01274-X. Epub 2015 Dec 21.
7
Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.心脏淀粉样变沉积的组织形态学模式与淀粉样变类型的相关性:108例病例的组织学和蛋白质组学分析
Histopathology. 2016 Apr;68(5):648-56. doi: 10.1111/his.12793. Epub 2015 Sep 28.
8
Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.冠状动脉微血管功能障碍与心脏淀粉样变性中心肌结构和功能的异常有关。
JACC Heart Fail. 2014 Aug;2(4):358-67. doi: 10.1016/j.jchf.2014.03.009. Epub 2014 Jul 9.
9
Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.同时存在多发性骨髓瘤或骨髓浆细胞增多的免疫球蛋白轻链淀粉样变性患者具有相同的高危人群特征。
J Clin Oncol. 2013 Dec 1;31(34):4319-24. doi: 10.1200/JCO.2013.50.8499. Epub 2013 Oct 21.
10
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.免疫球蛋白轻链淀粉样变性(AL)中器官受累及治疗反应的定义:2004年4月18 - 22日于法国图尔举行的第10届国际淀粉样变性和淀粉样变研讨会的共识意见
Am J Hematol. 2005 Aug;79(4):319-28. doi: 10.1002/ajh.20381.